A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...

Mental health professionals reveal the hidden signs of anxiety disorders affecting millions of Americans, from mysterious ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

A new review from the Cochrane Database of Systematic Reviews confirms that antidepressants can effectively reduce symptoms ...

A Boston VC firm is launching a new neuroscience company with a $93M investment that aims to treat disorders including ...

Canaccord analyst Sumant Kulkarni lowered the firm’s price target on Cybin (CYBN) to $73 from $86 and keeps a Buy rating on the shares. The ...

Virtual reality meditation effectively reduces depression and anxiety symptoms while improving emotional regulation in ...